journal article Jan 01, 2022

A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging

Parag Parekh Qingshan Mu Andrew Badachhape Rohan Bhavane Mayank Srivastava Laxman Devkota Xianwei Sun Prajwal Bhandari Jason L. Eriksen Eric Tanifum Ketan Ghaghada Ananth Annapragada

Theranostics Vol. 12 No. 12 pp. 5504-5521 · Ivyspring International Publisher

View at Publisher Save 10.7150/thno.72258

Topics

No keywords indexed for this article. Browse by subject →

Metrics

10

Citations

0

References

Details

Published: Jan 01, 2022
Vol/Issue: 12(12)
Pages: 5504-5521

Authors

From the Division of Pediatric Ophthalmology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania; the

Andrew Badachhape

Mayank Srivastava

Prajwal Bhandari

Jason L. Eriksen

Ananth Annapragada

Cite This Article

Parag Parekh, Qingshan Mu, Andrew Badachhape, et al. (2022). A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics, 12(12), 5504-5521. https://doi.org/10.7150/thno.72258

Related

You May Also Like

Ultrasound Elastography: Review of Techniques and Clinical Applications

Rosa M.S. Sigrist, Joy Liau · 2017

1,575 citations

Engineering exosomes for targeted drug delivery

Li Duan, Jianping Lu · 2021

1,335 citations

Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics

Lili Zou, Hong Wang · 2016

839 citations

The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges

Zhenyu Liu, Shuo Wang · 2019

836 citations

Platinum-based drugs for cancer therapy and anti-tumor strategies

Chunyu Zhang, Chao Xu · 2022

834 citations